Cargando…
Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response
Cervical cancer (CC) is the fourth ranking gynaecologic tumour in women worldwide, with respect to both incidence and mortality. MUC16 is one of the most frequently mutated genes, which functions as a tumour marker in CC. In the present study, mutation, clinical and RNA-Seq data collected from The C...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388571/ https://www.ncbi.nlm.nih.gov/pubmed/32765681 http://dx.doi.org/10.3892/etm.2020.8836 |